Investigating voice disorders caused by inhaled corticosteroids in asthma patients
Pathophysiology of Voice Disorders due to Combination Inhaled Corticosteroids in Asthma
This study is looking at how using combination inhaled medications for asthma might affect your voice, and it aims to find out why this happens so we can help prevent or fix any voice problems you might experience.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10909470 on NIH RePORTER |
What this research studies
This research focuses on understanding how combination inhaled corticosteroids, commonly used to manage asthma, can lead to voice disorders in patients. It aims to identify the underlying mechanisms that cause these voice changes, which can significantly impact communication and quality of life. The study will involve analyzing laryngeal biomarkers and other factors to develop new treatments that could prevent or reverse these disorders. By addressing this issue, the research seeks to improve the overall management of asthma and its associated complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with asthma who are using combination inhaled corticosteroids and are experiencing voice changes.
Not a fit: Patients who do not use inhaled corticosteroids or do not have voice disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of voice-sparing asthma medications that minimize the risk of voice disorders.
How similar studies have performed: While the specific focus on voice disorders related to inhaled corticosteroids is novel, there is existing research on the effects of asthma treatments on vocal health.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Barkmeier-Kraemer, Julie M — University of Utah
- Study coordinator: Barkmeier-Kraemer, Julie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.